CathRx sells first product to Europe

By Dylan Bushell-Embling
Wednesday, 17 September, 2008


CathRx [ASX: CXD] has secured the first sales of its diagnostic modular heart catheters to its UK distributor, in the company's first ever sale to Europe.

Cardiac catheters are minimally invasive tools widely used by specialist cardiologists to help diagnose and treat different types of cardiac arrhythmias.

The global market for cardiac catheters is predicted to be around $1.25 billion, with the European market alone worth $333.2 million.

CathRx plans to offer a progressively-expanding 'toolbox' of heart surgery tools to the European market in the next three quarters.

Related Articles

Breakthrough drug prevents long COVID symptoms in mice

Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction...

Antibiotics hinder vaccine response in infants

Infants who received antibiotics in the first few weeks of life had significantly lower levels of...

Colossal announces 'de-extinction' of the dire wolf

Colossal Biosciences has announced what it describes as the rebirth of the dire wolf, which would...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd